Literature DB >> 11433822

Apical hypertrophic cardiomyopathy (apical hypertrophy): an overview.

T Sakamoto1.   

Abstract

Clinical and laboratory data of apical hypertrophy were reviewed based on our experience of over 200 consecutive patients, of whom 126 patients were followed up by myself for more than 1 year (1 to 29 years). Emphasis was placed on various aspects of electrocardiography including the natural course and "wax and wane" phenomenon of giant negative T waves (GNT). Recent diagnostic modality, i.e., cardiac magnetic resonance imaging was also stressed. Apical hypertrophic cardiomyopathy (apical hypertrophy) was mainly discovered by annual health check including electrocardiography and characterized by giant negative T waves (GNT; -1.0-(-)4.2 mV) in the left precordial leads (V4 or V5) in middle-aged men. Transition from normal T wave to negative T wave required several years and remained usually unchanged thereafter. This change may occur rather abruptly on rare occasions. Disappearance of GNT may also occur slowly and progressively in patients, in whom apical aneurysm had developed. The diagnosis may be obtained with echocardiography, left ventriculography or ultrafast computed tomography, but was most accurate with cardiac magnetic resonance imaging, by which identification of the diversity of hypertrophy was achieved, because the multiple short-axis views were accurately obtained in addition to the exact long-axis view. Hypertrophy was not simple but quite complex in both morphology and grade. Gene abnormality may be present even in cases of apical hypertrophy. The prognosis of apical hypertrophy in Japan has been benign, and heart failure due to atrial fibrillation and left ventricular aneurysm due to the destruction of hypertrophied muscle are thought to have prognostic importance, but these were rare in our series.

Entities:  

Mesh:

Year:  2001        PMID: 11433822

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  21 in total

1.  The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited.

Authors:  B J Maron
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

2.  Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.

Authors:  Jeong Rang Park; Jin-Oh Choi; Hye Jin Han; Sung-A Chang; Sung-Ji Park; Sang-Chol Lee; Yeon Hyeon Choe; Seung Woo Park; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2011-04-24       Impact factor: 2.357

3.  Apical hypertrophic cardiomyopathy presenting as recurrent unexplained syncope.

Authors:  Yusuf Kasirye; Janaki Ram Manne; Narendranath Epperla; Sowjanya Bapani; Romel Garcia-Montilla
Journal:  Clin Med Res       Date:  2011-08-04

4.  Atypical hypertrophic cardiomyopathy on PET-myocardial perfusion study.

Authors:  Niti R Aggarwal; Philip A Araoz; Raymond J Gibbons; Todd D Miller
Journal:  J Nucl Cardiol       Date:  2011-12       Impact factor: 5.952

5.  Yamaguchi syndrome presenting as atrioventricular nodal re-entrant tachycardia in an African-American patient.

Authors:  Nellowe Candelario; Jorge Penalver; Mitali Sen
Journal:  BMJ Case Rep       Date:  2017-02-06

Review 6.  Pitfalls in the diagnosis of left ventricular hypertrabeculation/non-compaction.

Authors:  C Stöllberger; J Finsterer
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

Review 7.  Multimodality imaging in apical hypertrophic cardiomyopathy.

Authors:  Rosario Parisi; Francesca Mirabella; Gioel Gabrio Secco; Rossella Fattori
Journal:  World J Cardiol       Date:  2014-09-26

8.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

Review 9.  Value of electro-vectorcardiogram in hypertrophic cardiomyopathy.

Authors:  Andrés Ricardo Pérez-Riera; Augusto Armando de Lucca; Raimundo Barbosa-Barros; Frank G Yanowitz; Silvia Fortunato de Cano; Manuel Nicolás Cano; Antônio Carlos Palandri-Chagas
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-07       Impact factor: 1.468

10.  Apical hypertrophic cardiomyopathy in childhood: a long-term follow-up report of two cases.

Authors:  Tomoyuki Miyamoto; Hitoshi Horigome; Satoru Kawano; Ryo Sumazaki
Journal:  Pediatr Cardiol       Date:  2008-10-04       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.